| Whole genome sequencing of meticillin-resistant Staphylococcus aureus M Kuroda, T Ohta, I Uchiyama, T Baba, H Yuzawa, I Kobayashi, L Cui, ... The Lancet 357 (9264), 1225-1240, 2001 | 2650 | 2001 |
| Genome and virulence determinants of high virulence community-acquired MRSA T Baba, F Takeuchi, M Kuroda, H Yuzawa, K Aoki, A Oguchi, Y Nagai, ... The Lancet 359 (9320), 1819-1827, 2002 | 1934 | 2002 |
| The emergence and evolution of methicillin-resistant Staphylococcus aureus K Hiramatsu, L Cui, M Kuroda, T Ito Trends in microbiology 9 (10), 486-493, 2001 | 1388 | 2001 |
| Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus L Cui, X Ma, K Sato, K Okuma, FC Tenover, EM Mamizuka, CG Gemmell, ... Journal of clinical microbiology 41 (1), 5-14, 2003 | 696 | 2003 |
| Contribution of a Thickened Cell Wall and Its Glutamine Nonamidated Component to the Vancomycin Resistance Expressed by Staphylococcus aureus Mu50 L Cui, H Murakami, K Kuwahara-Arai, H Hanaki, K Hiramatsu Antimicrobial agents and chemotherapy 44 (9), 2276-2285, 2000 | 517 | 2000 |
| Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus L Cui, E Tominaga, H Neoh, K Hiramatsu Antimicrobial agents and chemotherapy 50 (3), 1079-1082, 2006 | 508 | 2006 |
| Whole-Genome Sequencing of Staphylococcus haemolyticus Uncovers the Extreme Plasticity of Its Genome and the Evolution of Human-Colonizing … F Takeuchi, S Watanabe, T Baba, H Yuzawa, T Ito, Y Morimoto, M Kuroda, ... Journal of bacteriology 187 (21), 7292-7308, 2005 | 413 | 2005 |
| Novel Mechanism of Antibiotic Resistance Originating in Vancomycin-Intermediate Staphylococcus aureus L Cui, A Iwamoto, JQ Lian, H Neoh, T Maruyama, Y Horikawa, ... Antimicrobial agents and chemotherapy 50 (2), 428-438, 2006 | 332 | 2006 |
| An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus L Cui, T Isii, M Fukuda, T Ochiai, H Neoh, ILBC Camargo, Y Watanabe, ... Antimicrobial Agents and Chemotherapy 54 (12), 5222-5233, 2010 | 239 | 2010 |
| Dissemination of methicillin-resistant staphylococci among healthy Japanese children K Hisata, K Kuwahara-Arai, M Yamanoto, T Ito, Y Nakatomi, L Cui, T Baba, ... Journal of Clinical Microbiology 43 (7), 3364-3372, 2005 | 225 | 2005 |
| DNA Microarray-Based Identification of Genes Associated with Glycopeptide Resistance in Staphylococcus aureus L Cui, JQ Lian, H Neoh, E Reyes, K Hiramatsu Antimicrobial Agents and Chemotherapy 49 (8), 3404-3413, 2005 | 222 | 2005 |
| Mutated Response Regulator graR Is Responsible for Phenotypic Conversion of Staphylococcus aureus from Heterogeneous Vancomycin-Intermediate … H Neoh, L Cui, H Yuzawa, F Takeuchi, M Matsuo, K Hiramatsu Antimicrobial agents and chemotherapy 52 (1), 45-53, 2008 | 201 | 2008 |
| Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus L Cui, H Neoh, M Shoji, K Hiramatsu Antimicrobial agents and chemotherapy 53 (3), 1231-1234, 2009 | 181 | 2009 |
| Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria K Kiga, XE Tan, R Ibarra-Chávez, S Watanabe, Y Aiba, Y Sato’o, FY Li, ... Nature communications 11 (1), 2934, 2020 | 178 | 2020 |
| walK and clpP Mutations Confer Reduced Vancomycin Susceptibility in Staphylococcus aureus M Shoji, L Cui, R Iizuka, A Komoto, H Neoh, Y Watanabe, T Hishinuma, ... Antimicrobial agents and chemotherapy 55 (8), 3870-3881, 2011 | 165 | 2011 |
| Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus Y Watanabe, L Cui, Y Katayama, K Kozue, K Hiramatsu Journal of Clinical Microbiology 49 (7), 2680-2684, 2011 | 161 | 2011 |
| Subinhibitory concentrations of β-lactam induce haemolytic activity in Staphylococcus aureus through the SaeRS two-component system H Kuroda, M Kuroda, L Cui, K Hiramatsu FEMS microbiology letters 268 (1), 98-105, 2007 | 158 | 2007 |
| Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin GA Oliveira, AM Dell'Aquila, RL Masiero, CE Levy, MS Gomes, L Cui, ... Infection Control & Hospital Epidemiology 22 (7), 443-448, 2001 | 156 | 2001 |
| Serial Daptomycin Selection Generates Daptomycin-Nonsusceptible Staphylococcus aureus Strains with a Heterogeneous Vancomycin-Intermediate Phenotype ILBC Camargo, HM Neoh, L Cui, K Hiramatsu Antimicrobial agents and chemotherapy 52 (12), 4289-4299, 2008 | 135 | 2008 |
| Mutation of RNA Polymerase β Subunit (rpoB) Promotes hVISA-to-VISA Phenotypic Conversion of Strain Mu3 M Matsuo, T Hishinuma, Y Katayama, L Cui, M Kapi, K Hiramatsu Antimicrobial agents and chemotherapy 55 (9), 4188-4195, 2011 | 128 | 2011 |
Hui-min NeohUKM Medical Molecular Biology Institute (UMBI), National University of Malaysia (UKM)Verified email at ppukm.ukm.edu.my